Quantum dot-based lab-on-a-bead system for multiplexed detection of free and total prostate-specific antigens in clinical human serum samples.

UNLABELLED An immunodiagnostic lab-on-a-bead suspension microarray based on microbeads encoded with quantum dots (QDs) has been developed and preclinically validated for multiplexed quantitative detection of prostate cancer markers in human serum samples. The sensitivity and specificity of the microarray are similar to those of "gold-standard" single-analyte ELISA. Moreover, the array has an improved immunoassay capacity, ensures quantitative detection of multiple cancer biomarkers and may be operational in a considerably wider dynamic range of concentrations. The array is characterized by reduced time and cost of analysis and is compatible with classical flow cytometers. Proof-of-concept preclinical tests ensured simultaneous quantitative determination of free and total prostate-specific antigens in human serum, with clear discrimination between the control and clinical samples. The proposed approach is flexible and paves the way to development of a wide variety of immunodiagnostic assays for multiplexed early diagnosis of various diseases. FROM THE CLINICAL EDITOR Early diagnosis of cancer can result in better prognosis for patients. Thus, the use of specific tumor markers is widely employed in clinical practice. Traditional screening methods only employ single markers. The authors here developed a microarray system based on microbeads encoded with quantum dots (QDs), which can be used for multiplexed quantitative detection. The validated results on patient samples should lead to the development of a wider variety of assays for other diseases.

[1]  P. Wadhwa,et al.  Validation and comparison of luminex multiplex cytokine analysis kits with ELISA: determinations of a panel of nine cytokines in clinical sample culture supernatants. , 2005, Journal of reproductive immunology.

[2]  A. Efimov,et al.  Combined scanning probe nanotomography and optical microspectroscopy: a correlative technique for 3D characterization of nanomaterials. , 2013, ACS nano.

[3]  Igor Nabiev,et al.  Biocompatible fluorescent nanocrystals for immunolabeling of membrane proteins and cells. , 2004, Analytical biochemistry.

[4]  A W Partin,et al.  Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: a prospective multicenter clinical trial. , 1998, JAMA.

[5]  Igor Nabiev,et al.  Highly Stable Fluorescent Nanocrystals as a Novel Class of Labels for Immunohistochemical Analysis of Paraffin-Embedded Tissue Sections , 2002, Laboratory Investigation.

[6]  Kevin Braeckmans,et al.  Encoding microcarriers: present and future technologies , 2002, Nature Reviews Drug Discovery.

[7]  N. Dubrawsky.  Cancer statistics , 1989, CA: a cancer journal for clinicians.

[8]  S. Nie,et al.  Quantum-dot-tagged microbeads for multiplexed optical coding of biomolecules , 2001, Nature Biotechnology.

[9]  Frank Caruso,et al.  Nanoengineering of particle surfaces. , 2001 .

[10]  A. W. Czarnik,et al.  Encoding methods for combinatorial chemistry. , 1997, Current opinion in chemical biology.

[11]  C. Sturgeon,et al.  Analytical error and interference in immunoassay: minimizing risk , 2011, Annals of clinical biochemistry.

[12]  J. Petrik,et al.  Diagnostic applications of microarrays , 2006, Transfusion medicine.

[13]  Jerome P. Richie,et al.  Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: a prospective multicenter clinical trial. , 1998, JAMA.

[14]  John P Nolan,et al.  Suspension array technology: evolution of the flat-array paradigm. , 2002, Trends in biotechnology.

[15]  S. Nock,et al.  Recent applications of protein arrays in target identification and disease monitoring. , 2004, Drug discovery today. Technologies.

[16]  Wen Li,et al.  Establishment of multiplexed, microsphere-based flow cytometric assay for multiple human tumor markers , 2007, Acta Pharmacologica Sinica.

[17]  Ken Wong,et al.  Issues and challenges , 1993 .

[18]  Hans-Gerd Löhmannsröben,et al.  Six-color time-resolved Förster resonance energy transfer for ultrasensitive multiplexed biosensing. , 2013, Journal of the American Chemical Society.

[19]  Guomin Wang,et al.  Development of simultaneous detection of total prostate‐specific antigen (tPSA) and free PSA with rapid bead‐based immunoassay , 2011, Journal of clinical laboratory analysis.

[20]  Jennifer S. Park,et al.  Qdot nanobarcodes for multiplexed gene expression analysis. , 2006, Nano letters.

[21]  Emanuel F Petricoin,et al.  Protein microarrays: meeting analytical challenges for clinical applications. , 2003, Cancer cell.

[22]  A. Jemal,et al.  Cancer statistics, 2013 , 2013, CA: a cancer journal for clinicians.

[23]  Andrew J. Vickers,et al.  Prostate-specific antigen and prostate cancer: prediction, detection and monitoring , 2008, Nature Reviews Cancer.

[24]  Abdelhamid Elaissari,et al.  Colloidal nanoparticles in biotechnology , 2008 .

[25]  Diane Gershon,et al.  Microarray technology: An array of opportunities , 2002, Nature.

[26]  Igor Nabiev,et al.  Oriented conjugates of single-domain antibodies and quantum dots: toward a new generation of ultrasmall diagnostic nanoprobes. , 2012, Nanomedicine : nanotechnology, biology, and medicine.

[27]  Zhixian Gao,et al.  Simultaneous and combined detection of multiple tumor biomarkers for prostate cancer in human serum by suspension array technology. , 2013, Biosensors & bioelectronics.

[28]  R J Fulton,et al.  Advanced multiplexed analysis with the FlowMetrix system. , 1997, Clinical chemistry.

[29]  Igor Nabiev,et al.  Nanocrystal-encoded fluorescent microbeads for proteomics: antibody profiling and diagnostics of autoimmune diseases. , 2007, Nano letters.

[30]  Xiaoyuan Chen,et al.  NIR-emitting quantum dot-encoded microbeads through membrane emulsification for multiplexed immunoassays. , 2013, Small.

[31]  Sean P. Palecek,et al.  Protein analytical assays for diagnosing, monitoring, and choosing treatment for cancer patients. , 2012, Journal of healthcare engineering.

[32]  J. P. McCoy,et al.  Multiplex bead array assays: performance evaluation and comparison of sensitivity to ELISA. , 2006, Methods.

[33]  Marina Cretich,et al.  Protein and peptide arrays: recent trends and new directions. , 2006, Biomolecular engineering.

[34]  Xiaoyuan Chen,et al.  Quantum Dots: NIR‐Emitting Quantum Dot‐Encoded Microbeads through Membrane Emulsification for Multiplexed Immunoassays (Small 19/2013) , 2013 .

[35]  W. Roberts,et al.  Intermethod differences in results for total PSA, free PSA, and percentage of free PSA. , 2008, American journal of clinical pathology.

[36]  Manuel Fuentes,et al.  Nanotechniques in proteomics: protein microarrays and novel detection platforms. , 2012, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[37]  Frank Caruso,et al.  Nanoengineering of Particle Surfaces , 2001 .

[38]  P. Wagner,et al.  Biomarkers in molecular medicine: cancer detection and diagnosis. , 2005, BioTechniques.

[39]  Igor Nabiev,et al.  Fluorescent Colloidal Particles as Detection Tools in Biotechnology Systems , 2007 .

[40]  J. P. McCoy,et al.  Multiplex bead array assays for detection of soluble cytokines: Comparisons of sensitivity and quantitative values among kits from multiple manufacturers , 2004, Cytometry. Part B, Clinical cytometry.

[41]  George G Klee,et al.  Antibody-based protein multiplex platforms: technical and operational challenges. , 2010, Clinical chemistry.

[42]  C. Sturgeon.  Practice guidelines for tumor marker use in the clinic. , 2002, Clinical chemistry.

[43]  D. Chan,et al.  Translation of proteomic biomarkers into FDA approved cancer diagnostics: issues and challenges , 2013, Clinical Proteomics.

[44]  Warren C W Chan,et al.  Quantum-dot-encoded microbeads for multiplexed genetic detection of non-amplified DNA samples. , 2011, Small.

[45]  sprotocols.  Engineering of ultra-small diagnostic nanoprobes through oriented conjugation of single-domain antibodies and quantum dots , 2015 .

[46]  Igor L. Medintz,et al.  Quantum dot bioconjugates for imaging, labelling and sensing , 2005, Nature materials.

[47]  Igor L. Medintz,et al.  Self-assembled nanoscale biosensors based on quantum dot FRET donors , 2003, Nature materials.

[48]  Marie A. Iannone,et al.  Multiplexed Microsphere‐Based Flow Cytometric Assays , 2003 .

[49]  Xiaomei Yan,et al.  Multiplex immunodetection of tumor markers with a suspension array built upon core-shell structured functional fluorescence-encoded microspheres. , 2010, Analytica chimica acta.

[50]  T. Kodadek.  Protein microarrays: prospects and problems. , 2001, Chemistry & biology.

[51]  Yajie Wang,et al.  Evaluation of a method for the simultaneous detection of multiple tumor markers using a multiplex suspension bead array. , 2012, Clinical biochemistry.

[52]  F. Caruso,et al.  Formation of luminescent spherical core-shell particles by the consecutive adsorption of polyelectrolyte and CdTe(S) nanocrystals on latex colloids , 2000 .

[53]  K. Bensalah,et al.  Challenges of cancer biomarker profiling. , 2007, European urology.

[54]  R. Nitschke,et al.  Quantum dots versus organic dyes as fluorescent labels , 2008, Nature Methods.

[55]  Igor Nabiev,et al.  Fluorescent nanocrystal-encoded microbeads for multiplexed cancer imaging and diagnosis. , 2008, Critical reviews in oncology/hematology.

[56]  Reinhard Niessner,et al.  Multiplex competitive microbead-based flow cytometric immunoassay using quantum dot fluorescent labels. , 2012, Analytica chimica acta.